17-31229146-T-C
Variant summary
Our verdict is Pathogenic. Variant got 19 ACMG points: 19P and 0B. PM1PM2PM5PP2PP3_StrongPP5_Very_Strong
The NM_001042492.3(NF1):c.2531T>C(p.Leu844Pro) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 13/21 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. L844F) has been classified as Pathogenic.
Frequency
Consequence
NM_001042492.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 19 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Neurofibromatosis, type 1 Pathogenic:5
- -
This sequence change replaces leucine, which is neutral and non-polar, with proline, which is neutral and non-polar, at codon 844 of the NF1 protein (p.Leu844Pro). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with neurofibromatosis type 1 (PMID: 15060124, 29290338). ClinVar contains an entry for this variant (Variation ID: 68322). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt NF1 protein function. This variant disrupts the p.Leu844 amino acid residue in NF1. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 10980545, 15060124, 27322474, 29290338). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. -
- -
The NF1 gene is constrained against variation (Z-score= 8.42 and pLI = 1), and missense variants are a common mechanism of disease (PMID: 20301288). The c.2531T>C (p.Leu844Pro) variant affects a highly conserved amino acid and is predicted by multiple in silico tools to have a deleterious effect on protein function. This variant has been previously reported as a heterozygous change in individuals with neurofibromatosis type 1 (PMID: 15060124, 29290338). The c.2531T>C (p.Leu844Pro) variant is located in the cysteine-serine rich (CSR) domain, which is a known hotspot domain for pathogenic variations associated neurofibromatosis type 1 (PMID: 34230207, 29290338). Different amino acid changes at the same residue (p.Leu844Phe; p.Leu844His, p.Leu844Arg) have been previously reported in individuals with neurofibromatosis type 1 (PMID: 29290338, 9150739, 10980545). The c.2531T>C (p.Leu844Pro) variant is absent from the latest version of the gnomAD population database and thus is presumed to be rare. Based on the available evidence, c.2531T>C (p.Leu844Pro) is classified as Likely Pathogenic. -
- -
not provided Pathogenic:1Other:1
- -
Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 24803665, 15060124, 29290338, 25486365, 2121369) -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at